Use of a medical cannabinoid product, as defined in M.S. § 342.01, that meets all requirements under applicable law, by a patient enrolled and registered in the medical cannabis program, is not subject to the prohibition contained in § 133.002. This exemption does not apply to the smoking or vaporizing of medical cannabinoid products, as defined in M.S. § 342.01, in public places.
(Ord. 1007, passed 9-11-2023)